The purpose of The Brain Care Study is to investigate the prevalence of cognitive impairment in older adults with type 2 diabetes (T2D) and to evaluate the effectiveness of a multidomain intervention designed to prevent cognitive decline.
Age ≥ 65 years
Diagnosis of Type 2 Diabetes (T2D)
Patient at the outpatient clinic at either Bispebjerg Hospital, Rigshospitalet, or Steno Diabetes Center Copenhagen
Speaks and understands Danish (required for the cognitive tests)
Diagnosis of dementia or prior referral to a dementia clinic
Diagnosis of psychiatric, neurological, or other disorders that, in the investigator's opinion, hinder participation in cognitive screening, preclude compliance with the study protocol, or affect the evaluation of results
Meets all the above exclusion criteria
Participants whose cognitive MoCA screening indicates dementia will be excluded and advised to contact their physician